| 名稱 | TCR Activator/Raji |
| 型號(hào) | CBP74015 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | TCR Activator/Raji，凍存條件：90% FBS+10% DMSO； |
產(chǎn)品搜索
相關(guān)文章
- 人結(jié)腸癌細(xì)胞株的生長(zhǎng)曲線分析
- 腫瘤細(xì)胞的凋亡與壞死有何區(qū)別？
- 【產(chǎn)品推介】RANKL抗體篩選模型
- 4-1BB（CD137）靶點(diǎn)藥物篩選模型
- KRAS G12C耐藥突變藥篩細(xì)胞模型
- CD47/PD-(L)1 雙靶點(diǎn)細(xì)胞篩選模型簡(jiǎn)介
- 慢病毒整合位點(diǎn)標(biāo)準(zhǔn)品強(qiáng)勢(shì)來(lái)襲
- PTPRZ1-MET腦膠質(zhì)瘤分子診斷標(biāo)準(zhǔn)品上新
- EGFR 20外顯子突變類型標(biāo)準(zhǔn)品
- 探討腫瘤細(xì)胞的“冷與熱”之分
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74015TCR Activator/Raji
- 詳細(xì)內(nèi)容
TCR Activator/Raji
| CBP74015 | |
| I. Background | |
| N/A | |
| II. Description | |
| Recombinant RAJI cell constitutively expressing a membrane bound, engineered T cell receptor (TCR) activator. | |
| III. Introduction | |
| Host Cell: | RAJI |
| Expressed gene: | TCR activator |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | RPMI-1640+10%FBS+1ug/ml puromycin |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| Application(s): | Functional(Report Gene) Assay |
| IV. Description of Host Cell Line | |
| Organism: | Homo sapiens,human |
| Tissue: | Lymphoblast |
| Disease: | Burkitt's lymphoma |
| Morphology: | Lymphoblast |
| Growth Properties: | Suspension |
| Ⅴ. Representative Data | |
Figure 1. Jurkat NFAT Luciferase Reporter Activity.
Figure 2. Response of IL-2-Luciferase Reporter Jurkat Cell Line (C29) to Raji TCR Activator Cell Line.
| |
| Figure 3. Dose Response of Recombinant hCTLA4-Fc in IL2 Promoter Reporter-Jurkat Cells with TCR Activitor Raji Cells. | |
會(huì)員_a.png)